Now showing items 1-7 of 7
Bioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of Bioequivalence
(Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media, 1998-02)
In Vivo Percutaneous Penetration/Absorption, Washington, D.C., May 1989
(Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media, 1991-08)
In vivo percutaneous penetration/absorption : Sponsored by the American Association of Pharmaceutical Scientist, U.S. Food and Drug Administration, American Academy of Dermatology, Skin Pharmacology Society and the U.S. Army Environmental Hygiene Agency May 1-3, 1989, Washington, DC
(Elsevier, 1991-08-02)
This workshop, `In Vivo Percutaneous Penetration/Absorption' was held in Washington, DC, on May 1-3, 1989. The first workshop in this series, `In Vitro Percutaneous Penetration', took place in November 1986 (the report of ...
FDA and AAPS Report of the Workshop on Principles and Practices of In Vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalence
(Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media, 1987-06)
In Vitro and in Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms
(Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media, 1990-09)
Assessment of Value and Applications of In Vitro Testing of Topical Dermatological Drug Products
(Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media, 1999-09)
The FDA recently issued a guidance covering practices of scaleup and post approval changes with semisolids (SUPAC-SS). This guidance outlines the steps that must be taken by a company to maintain certification of its ...